Prohibitin interacts with phosphatidylinositol 3,4,5-triphosphate (PIP3) and modulates insulin signaling

Biochemical and Biophysical Research Communications

Volumn 390, Issue 3, 2009, Pages 1023-1028

  Ande, Sudharsana R ^a   Mishra, Suresh ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Akt; Insulin; Lipid binding domain; Lipid protein interaction; PIP3; Prohibitin; Tyrosine phosphorylation

Indexed keywords

GROWTH FACTOR; INSULIN; LIPID BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PROHIBITIN; PROTEIN KINASE B;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; GENE OVEREXPRESSION; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

3T3-L1 CELLS; AMINO ACID SEQUENCE; ANIMALS; HUMANS; INSULIN; MICE; MOLECULAR SEQUENCE DATA; PHOSPHATIDYLINOSITOL PHOSPHATES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; TYROSINE;

EID: 70449705816     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.10.101     Document Type: Article

References (21)

1. Cohen P. The twentieth century struggle to decipher insulin signaling. Nat. Rev. Mol. Cell Biol. 7 (2006) 867-873
2. Taniguchi C.M., Emanuelli B., and Kahn C.R. Critical nodes in signalling pathways: insights into insulin action. Nat. Rev. Mol. Cell Biol. 7 (2006) 85-96
3. Wijesekara N., et al. Muscle-specific Pten deletion protects against insulin resistance and diabetes. Mol. Cell. Biol. 25 (2005) 1135-1145
4. Sleeman M.W., et al. Absence of the lipid phosphatase SHIP2 confers resistance to dietary obesity. Nat. Med. 11 (2005) 199-205
5. Yang X., Ongusaha P.P., Miles P.D., Havstad J.C., Zhang F., So W.V., Kudlow J.E., Michel R.H., Olefsky J.M., Field S.J., and Evans R.M. Phosphoinositide signalling links O-GlcNAc transferase to insulin resistance. Nature 451 (2008) 964-969
6. Osman C., Haag M., Potting C., Rodenfels J., Dip P.V., Wieland F.T., Brugger B., Westermann B., and Langer T. The genetic interactome of prohibitins: coordinated control of cardiolipin and phosphatidylethanolamine by conserved regulators in mitochondria. J. Cell Biol. 184 (2009) 583-596
7. Ande S.R., Moulik S., and Mishra S. Interaction between O-GlcNAc modification and tyrosine phosphorylation of prohibit. implication for a novel binary switch. PLoS ONE 4 2 (2009) e4586
8. S.R. Ande, Y. Gu, B.L.G. Nyomba, S. Mishra, Insulin induced phosphorylation of prohibitin at tyrosine114 recruits Shp1, BBA-Mol. Cell Res. (2009), doi: 10.1016/j.bbamcr.2009.05.008.
9. Han E.K., Mcgonigal T., Butler C., Giranda V.L., and Luo Y. Characterization of Akt overexpression in MiaPaCa-2 cells: prohibitin is an Akt substrate both in vitro and in cells. Anticancer Res. 28 (2008) 957-963
10. Birner R., Nebauer R., Schneiter R., and Daum G. Synthetic lethal interaction of the mitochondrial phosphatidylethanolamine biosynthetic machinery with the prohibitin complex of Saccharomyces cerevisiae. Mol. Biol. Cell 14 (2003) 370-383
11. Browman D.T., Resek M.E., Zajchowski L.D., and Robbins S.M. Erlin-1 and erlin-2 are novel members of the prohibitin family of proteins that define lipid-raft-like domains of the ER. J. Cell Sci. 119 (2006) 3149-3160
12. Whelan S.A., Lane M.D., and Hart G.W. Regulation of the O-linked beta-N-acetylglucosamine transferase by insulin signaling. J. Biol. Chem. 283 (2008) 21411-21417
13. Kane L.P., and Weiss A. The PI-3 kinase/Akt pathway and T cell activation: pleiotropic pathways downstream of PIP3. Immunol. Rev. 192 (2003) 7-20
14. Balla T. Inositol-lipid binding motifs: signal integrators through protein-lipid and protein-protein interactions. J. Cell Sci. 118 (2005) 2093-2104
15. Cai C.Z., Han L.Y., Ji Z.L., Chen X., and Chen Y.Z. SVM-Prot: web-based support vector machine software for functional classification of a protein from its primary sequence. Nucleic Acids Res. 31 (2003) 3692-3697
16. Sato T.K., Overduin M., and Emr S.D. Location, location, location: membrane targeting directed by PX domains. Science 294 (2001) 1881-1885
17. Back J.W., Sanz M.A., De Jong L., De Koning L.J., Nijtmans L.G., De Koster C.G., Grivell L.A., Van Der Spek H., and Muijsers A.O. A structure for the yeast prohibitin complex: structure prediction and evidence from chemical crosslinking and mass spectrometry. Protein Sci. 11 (2002) 2471-2478
18. Cheng J.Q., Lindsley C.W., Cheng G.Z., Yang H., and Nicosia S.V. The Akt/PKB pathway: molecular target for cancer drug discovery. Oncogene 14 (2005) 7482-7492
19. Zick Y. Ser/Thr phosphorylation of IRS proteins: a molecular basis for insulin resistance. Sci. STKE (2005) PE4
20. Du K., Herzig S., Kulkarni R.N., and Montminy M. TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver. Science 300 (2003) 1574-1577
21. Kikani C.K., Dong L.Q., and Liu F. "New"-clear functions of PDK1: beyond a master kinase in the cytosol?. J. Cell. Biochem. 96 (2005) 1157-1162